Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$39.13 - $47.24 $395,995 - $478,068
10,120 Added 11.28%
99,815 $4.04 Million
Q2 2023

Aug 14, 2023

BUY
$43.93 - $46.76 $3.94 Million - $4.19 Million
89,695 New
89,695 $4.04 Million
Q4 2022

Feb 14, 2023

BUY
$41.91 - $50.48 $3.78 Million - $4.55 Million
90,137 Added 152.17%
149,373 $7.45 Million
Q3 2022

Nov 14, 2022

BUY
$40.9 - $50.42 $2.15 Million - $2.65 Million
52,501 Added 779.52%
59,236 $2.45 Million
Q2 2022

Aug 15, 2022

SELL
$42.98 - $49.77 $1.58 Million - $1.83 Million
-36,831 Reduced 84.54%
6,735 $318,000
Q1 2022

May 16, 2022

BUY
$42.23 - $54.3 $1.12 Million - $1.44 Million
26,602 Added 156.81%
43,566 $2.14 Million
Q4 2021

Feb 14, 2022

BUY
$50.62 - $56.47 $586,685 - $654,487
11,590 Added 215.67%
16,964 $943,000
Q3 2021

Nov 15, 2021

SELL
$46.55 - $56.83 $546,403 - $667,070
-11,738 Reduced 68.6%
5,374 $278,000
Q2 2021

Aug 16, 2021

SELL
$46.28 - $52.75 $95,707 - $109,087
-2,068 Reduced 10.78%
17,112 $828,000
Q1 2021

May 17, 2021

BUY
$46.25 - $56.02 $887,075 - $1.07 Million
19,180 New
19,180 $934,000
Q1 2020

May 15, 2020

SELL
$33.17 - $41.6 $2.08 Million - $2.61 Million
-62,633 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$25.41 - $43.1 $1.04 Million - $1.76 Million
40,777 Added 186.57%
62,633 $2.12 Million
Q3 2019

Nov 14, 2019

BUY
$32.73 - $40.81 $715,346 - $891,943
21,856 New
21,856 $721,000
Q4 2018

Feb 14, 2019

SELL
$32.65 - $37.95 $253,494 - $294,643
-7,764 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$35.99 - $39.39 $279,426 - $305,823
7,764 New
7,764 $294,000
Q4 2017

Feb 14, 2018

SELL
$30.68 - $35.37 $312,567 - $360,349
-10,188 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$31.02 - $32.94 $316,031 - $335,592
10,188
10,188 $321,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.24B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.